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Abstract
Glutamate receptors of the kainate type (Kainate receptors, KARs), are media-
tors of ionotropic postsynaptic synaptic transmission, as well as presynaptic 
modulators of neurotransmitter release where they show both ionotropic and 
metabotropic actions regulating glutamate and γ-aminobutiric acid (GABA) release. 
The mechanisms underlying these modulatory roles are starting to be understood at 
some brain regions. Here we review the KARs roles and mechanisms involved in the 
modulation of glutamate release in the cerebellum at parallel fibers (PF)-Purkinje 
Cells (PuC) synapses. KARs activation mediate a biphasic effect on glutamate 
release at this synapse, with low kainate (KA) concentrations mediating a facilita-
tion of glutamate release and higher KA concentrations mediating a depression of 
glutamate release. KA-mediated facilitation is prevented by antagonizing KARs, 
by inhibition of PKA or stimulation of adenylyl cyclase (AC), by blocking Ca2+ 
permeant KARs, by depleting intracellular Ca2+ stores and by blocking calmodulin. 
Thus, at cerebellar parallel fiber-Purkinje cell synapses, presynaptic KARs medi-
ate glutamate release facilitation through Ca2+-calmodulin dependent activation 
of adenylyl cyclase/cAMP/protein kinase A signaling. KAR-mediated depression 
of glutamate release involves the AC/cAMP/PKA pathway as for facilitation but 
not Ca2+-calmodulin, being in this case AC activated by a Gi/o protein to mediate a 
depression of glutamate release.
Keywords: cerebellum, KARs, glutamate release, presynaptic, PKA, adenylate 
cyclase, Ca2+ calmodulin
1. Introduction
Glutamate is the most abundant excitatory neurotransmitter in the central 
nervous system (CNS) of mammals. Glutamate mediates its actions by activating 
glutamate receptors. These receptors participate in normal synaptic transmission at 
different synapses, in plasticity processes as long-term potentiation (LTP) and long-
term depression (LTD) that are considered the cellular and molecular correlation 
of memory and learning processes and in synaptogenesis and neuronal maturation 
and, additionally, failure in the functioning of this system can be the origin of some 
types of epilepsy and may contribute to the development of CNS disorders such as 
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Alzheimer’s disease, Huntington’s Korea, amyotrophic lateral sclerosis, Parkinson’s 
disease, hypoglycemia, or cerebral ischemia [1–3].
Glutamate receptors are classically divided into two large families: ionotropic 
and metabotropic. Ionotropic glutamate receptors (iGluRs) participate in rapid 
neurotransmission in the nervous system; these ionotropic receptors are classified 
into three types depending on the agonist that activates them with higher affinity: 
N-methyl-d-aspartic acid (NMDA) receptors (NMDARs), α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPARs), and kainate 
receptors (KARs). These receptors form a channel with different selectivity 
depending on their subunit composition, all of them being permeable to Na+ and 
K+ and, additionally, NMDARs are permeable to Ca2+ been some AMPARs and 
KARs also permeable to Ca2+ depending on subunit composition. They are inte-
gral membrane proteins, formed by four subunits (tetramers), being homomers 
or heteromers [1, 2].
Metabotropic glutamate receptors (mGluRs), which participate also in 
neurotransmission, are coupled to G proteins and are divided into eight types 
(mGluR 1–8) and three groups of receptors: group I mGluRs includes mGluR1 
and mGluR5 receptors. These receptors are positively coupled to phospholipase C 
(PLC), which facilitates the conversion of inositol diphosphate (PIP2) to diacyl-
glycerol (DAG) and inositol triphosphate (IP3). DAG activates protein kinase C 
(PKC) that phosphorylates different substrates and IP3 causes numerous intra-
cellular effects, including the facilitation of Ca2+ release from intracellular stores. 
Group II mGluRs includes mGluR2 and mGluR3 receptors. These receptors are 
negatively coupled to adenylate cyclase-mediated AMPc formation, and group 
III mGluRs includes mGluR4, mGluR6, mGluR7, and mGluR8 receptors. These 
receptors are negatively coupled to the formation of AMPc mediated by adenyl-
ate cyclase [4].
1.1 Kainate receptors
Kainate (KA) is a potent neurotoxin derived from the alga Digenea simplex. The 
word “Kainic” is derived from the Japanese “Kaininso” (“Makuri”), which means 
“the ghost of the sea,” and it is an agonist for both KARs and AMPARs (in the same 
way that the AMPARs agonist AMPA may activate KARs). Kainate is classically 
known for its potent epileptogenic actions [5, 6].
KA (and other agonists) activates KARs that are tetramers that resulted from 
different combinations of five subunits called GluK1, GluK2, GluK3, GluK4, and 
GluK5 (formerly known as GluR5, GluR6, GluR7 and KA1, and KA2, respectively). 
Of these subunits, GluK1 and GluK3 may form homomeric or heteromeric func-
tional receptors, while GluK4 and GluK5 may only participate in functional recep-
tors when associated with any of the GluK1, GluK2, or GluK3 subunits, but they do 
not combine with subunits of AMPARs [1, 7, 8].
KARs have been described in different invertebrates such as nematodes and 
flies [9, 10] and in different species of vertebrates such as amphibia, fish, and birds 
[11–13] in addition to mammals. In mammals, KARs have been observed virtually 
throughout the entire nervous system, although their subcellular location has not 
been yet fully determined. KARs are widely distributed throughout the CNS and 
found in the main cells and interneurons of the hippocampus, lateral amygdala, 
dorsal root ganglia, bipolar cells of the retina, cerebral cortex, and the cerebellum 
[14, 15].
The lack of knowledge about these receptors compared to other glutamatergic 
receptors (AMPARs or NMDARs) has been due to the lack of good agonist and 
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antagonist for receptors with particular subunit compositions and to the absence of 
specific antibodies for the different subunits of KARs, being therefore a significant 
limitation when exploring the distribution of these receptors. However, by using 
in situ hybridization techniques, it has been observed that the cells that present 
a significant expression of the kainate-type subunits GluK1, GluK2, GluK3, and 
GluK5 are distributed throughout the CNS, including nucleus striatum, hippocam-
pus, cortex, and cerebellum [16]. Likewise, there is a high expression of the GluK4 
subunit in the CA3 region of the hippocampus, as well as in the granular neurons of 
the dentate gyrus. The messenger of the GluK5 subunit, on the other hand, appears 
more abundantly and more extensively than that of the GluK4 subunit or those of 
the other subunits [15]. Because the in situ hybridization technique is informative 
and cannot reveal the subcellular distribution of a specific subunit, and because of 
pharmacological limitations, there is still much to know about the subcellular loca-
tion and physiology of these receptors.
Kainate-type glutamate receptors are well established mediators of canonical, 
ionotropic postsynaptic synaptic transmission and, presynaptically, have a modula-
tory role in regulating neurotransmitter release. In the latter regard, KARs have 
been shown to have a noncanonical metabotropic capacity, whereby they affect the 
control of both glutamate and GABA release, for review see [15, 17–22]. At some 
excitatory glutamatergic synapses, KARs’ activation can actually effect biphasic 
modulation, where low agonist concentrations facilitate glutamate release, while 
high concentrations decrease the release of the neurotransmitter, for review see 
[17, 18]. Mechanistic details of how this is achieved are subject of investigation and, 
indeed, the subcellular location of KARs responsible for presynaptic modulation 
remains contentious. Different roles of KARs in plasticity have also been described 
either in LTP or LTD, see [23] for a review of the role of KARs in plasticity.
As other glutamate receptors, KARs are directly or indirectly involved in dif-
ferent diseases, alterations of the nervous system and neurodegeneration and cell 
death processes. As previously indicated, KA is a potent neurotoxin that directly 
induces epilepsy and is used as a temporal lobe epilepsy model [5, 6]. Several lines 
of research indicate that KA directly activating KARs is involved in excitatory 
and inhibitory imbalances associated with epilepsy. The use of animal models for 
epilepsy through the use of KA injections has allowed to reproduce in great detail 
the symptoms observed in humans. The majority of studies of KARs’ involvement 
in epilepsy have studied acute KA-induced seizures [24–27]. The best demonstra-
tions of a mechanism for KARs’ involvement in acute epilepsy come from studies of 
inhibition of GABA release by the activation of presynaptic KA receptors at inter-
neuron-CA1 hippocampal synapses [24, 28, 29]. In chronic epilepsy, a role of KARs 
has been demonstrated at hippocampal mossy fibers making aberrant synapses onto 
granule cells of dentate gyrus expressing high number of KARs [30–32] reviewed 
in [6, 33]. In humans, genetic studies of members of a family affected by idiopathic 
juvenile absence epilepsy found elevated levels of Grik1 polymorphisms [34], and 
in TLE patients, GluK1 subunit containing KARs’ increased levels have also been 
found [35]. In clinical studies, NS1209 (an AMPA/KARs’ antagonist) has been 
found to decrease epileptic symptoms [36].
Different studies of neurotoxicity clearly indicate that KARs might be impor-
tant targets for neuroprotection in neurons and glial cells. The mechanism by 
which KARs produce excitotoxicity and neuronal cell death is not well understood 
mainly because of the limitations in appropriate pharmacological tools. Toxicity 
of KARs involved in multiple sclerosis has also been found onto oligodendrocytes 
and myelin related to [37, 38], and damage has also been found at axonal levels, 
where AMPA/KARs’ antagonists prevent it [39]. Interestingly, KARs have also been 
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involved in pain. They are present at dorsal roots activating nociceptors, actually 
there are clinical trials using KARs’ antagonists to try to prevent pain showing 
some levels of analgesia [36]. Additionally, KARs have been involved in ischemia 
[40, 41], migraine pain [36], Alzheimer’s disease [42], Parkinson’s disease [43, 44], 
Huntington’s Chorea [45–47], Schizophrenia [48, 49], depression [50], bipolar dis-
order [51, 52], mental retardation [53], and autism [54, 55] as reviewed in [56]. In 
general, antagonists of KARs containing particular subunits might be good targets 
to ameliorate symptoms or treat different CNS diseases and alterations.
2. KARs in the cerebellum
As indicated above, KARs are expressed in the cerebellar cortex [57–59]. As 
known, the cerebellum participates in the modulation of movement by modifying 
the activity patterns of motor neurons. Structurally, the cerebellum is composed 
of the laminar cerebellar cortex and the deep cerebellar nuclei and has five types 
of cells: Purkinje, stellate, basket, Golgi, and granule cells. Purkinje cells (PuC) are 
aligned in front of each other. Their dendritic trees form two 2-dimensional layers 
through which parallel fibers from the mossy fibers located in the granular layer 
pass. These parallel fibers (PF) establish excitatory synapses between granular cells 
and the spines of the PCs dendrites as well as the climbing fibers (CF, originating 
from the inferior olivary nucleus) with the nearby dendrites and the cellular soma. 
The parallel fibers pass orthogonally through the dendritic tree of the Purkinje 
neuron. Up to 200,000 PF form a synapse with a single PuC. Each PuC receives up to 
500 synapses of CF, all originated from a single CF. Both basket cells and stellate cells 
provide an inhibitory (GABAergic) entry to the PuC, with cells in the basket synapse 
to the initial segment of the PuC axon, and stellate cells to the dendrites [60, 61].
Presynaptic KARs participate in plasticity in the cerebellum where PF synapses 
onto PuCs mediate a form of LTD that is affected by the paired activation of CFs 
[62], Table 1; of these two types of fibers (PF and CF synapsing onto the same 
cells (PC), only PF have presynaptic KARs [62], similar to other brain regions as 
somatosensory and visual cortices in which fibers containing and noncontaining 
presynaptic ionotropic glutamate receptors synapse onto the same postsynaptic cell 
and induce LTD [63–69]. The exact role and action mechanism of KARs mediating 
LTD in the cerebellum are not well known yet and await further investigation.
The proper cerebellum development depends on a precise coordinated sequence 
of postnatal events, some of which are mediated by glutamate receptors. For 
example, NMDA receptors have been implicated in the migration of granular 
cells [70] and in the synaptic pruning of climbing fibers [71]. Although it has 
recently been shown that KARs are involved in synaptic transmission, little is 
known about their role in development. However, the expression of kainate-type 
glutamate receptor subunits in immature granule cells of the outer germinal layer 
of the developing cerebellum suggests that KARs may also have a role in neuronal 
maturation. Throughout the maturation process of the cerebellum, the quantity, 
composition, and function of KARs vary. Initially, cerebellar granular cells have a 
minimal amount of AMPARs in the postnatal period compared to KARs, which are 
predominant in immature granule cells. Different studies have shown that KARs 
composed of subunits GluK1, GluK2, and GluK5 predominate, and over the period 
of development, an increase in the number of KARs is observed and once the adult 
stage is reached, the number of KARs containing GluK1 subunits suffers a reduction 
in their expression in the granular layer, while the GluK2 and GluK5 remain con-
stant, in contrast to AMPARs that increase their number, constituting a very notable 
majority compared to KARs.
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All of these findings suggest that KARs have an important role in the develop-
ment process of the cerebellum. Some indications suggest that GluK1-containing 
KARs participate in cerebellar development in the beginning of the differentiation 
of granular cells.
Additionally, KARs have been involved in some brain alterations in the cerebellum 
and a direct relationship exists between KA injection and cerebellar ataxia. Thus, the 
cerebellum is an important target to study functions of KARs and its possible role 
causing ataxia [72–75]. Furthermore, in patients with schizophrenia, an increase in 
KARs containing GluR6 and K2 subunits is observed, which would mediate a reduc-
tion in GABAergic transmission [76, 77]. In neurodegeneration, KARs may have a role 
in calcification of the brain tissue as it has been found that local application of KA in 
some areas of the cerebellum produces changes in different ion levels, highly increas-
ing Ca2+ levels for more than 8 weeks, which mediate calcification [78] (Table 1). 
KARs have been described as producing increases in intracellular calcium [79, 80] and 
seems to signal increasing intracellular calcium without putting the cell at risk due to 
excitotoxicity, due to its low conductance in contrast to AMPARs. Due to the lack of 
knowledge on the subject, further exploration is necessary to determine the KARs’ 
role in cerebellum development and cerebellar alterations.
2.1 KARs modulating glutamate release in the cerebellum: a biphasic effect
KARs are known to be expressed in the cerebellar cortex in the axons of cer-
ebellar granule cells that form PF and make excitatory synapses with PuC [58]. 
Messenger RNA transcripts encoding for different KAR subunits and functional 
expression of KAR subtypes have been reported [81–84]. Biophysical studies with 
single-channel recording have shown GluK1 activity [85], suggesting these KARs 
are Ca2+ permeable. A biphasic action of KARs, activated by the agonist domoate, 
has been shown previously at PF-PuC synapse, with low agonist concentrations, 
facilitating synaptic transmission and higher concentrations depressing synaptic 
KARs’ activation High concentrations 
of kainate
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transmission [86] in agreement with what has been found in the hippocampus 
[87–89], cortex [90], amygdala [91], and the thalamus [92]. EPSC trial-to-trial 
fluctuation analysis, failure rates, as well as paired-pulse ratios have shown that 
these facilitatory and depressive actions of KARs in the cerebellum are mediated by 
presynaptic KARs [80]. However, the precise mechanism of action by which KARs 
mediate potentiation (and depression) of synaptic transmission at PF-PuC synapses 
has remained elusive until very recently [80] (Table 1).
2.1.1  Action mechanism for KARs-mediated facilitation of glutamate release at 
cerebellar PF-PuC synapses
We have recently demonstrated that the effect of the KARs’ activation in this 
synapse requires protein kinase A (PKA) activation, since the inhibition of this 
protein by cAMP-Rp suppresses the effect of KA in glutamate release [80], in agree-
ment with previous studies in hippocampus and cortex [87–89]. This congruence 
between mechanisms at different synapses has also been seen through the inhibition 
of PKA using H-89, which eliminates KARs-mediated facilitation of glutamate 
release. Similarly, the direct activation of AC (adenylyl cyclase) using forskolin 
caused an elimination of facilitation when KARs were activated by KA (with 
NMDARs and AMPARs blocked). These data indicate that a signaling mediated by 
AC/cAMP/PKA supports the facilitation of the modulation of synaptic transmis-
sion/glutamate release in these cerebellar synapses (Figures 1–3).
As observed in other synapses, Ca2+ seems to play a fundamental role in facilitat-
ing glutamate release at PF-PuC synapses. By blocking calcium-permeable KARs 
by the selective inhibitor philanthotoxin, KAR-mediated synaptic facilitation of 
glutamate release was prevented, indicating that there is a strict requirement for 
external Ca2+ entry through KARs to support the facilitation effect observed on 
glutamate release, indicating that KARs mediating the facilitation of glutamate 
release are calcium permeable [80].
Additionally, as has been reported at hippocampal synapses, the depletion of 
intracellular Ca2+ stores by a treatment with thapsigargin (a noncompetitive cal-
cium inhibitor of the sarcoplasmic reticulum ATPase) eliminates the facilitation of 
glutamate release mediated by KARs’ activation. The same result was found when 
selectively inhibiting Ca2+-induced calcium release by using ryanodine, indicating 
that the entry of Ca2+ via KARs induces a mobilization of Ca2+ from the intratermi-
nal Ca2+ reserves to mediate the increase in glutamate release observed [80].
Furthermore, it has been observed that the facilitation of glutamate release 
mediated by the activation of KARs is sensitive to calmodulin inhibitors. Previous 
studies showed that the increase of cytosolic calcium levels activates Ca2+ depen-
dent on AC present in the terminals of parallel fibers. Through treatment with the 
calmodulin inhibitors, W-7 and calmidazolium, it has been recently shown [80] that 
the inhibition of calcium-calmodulin function prevents KAR-mediated presynaptic 
facilitation of glutamate release in cerebellar slices, supporting the hypothesis 
that after KAR activation and cytosolic elevation of Ca2+, a calmodulin-dependent 
calcium coupling activates AC, which subsequently activates the AC/cAMP/PKA 
pathway, thus promoting synaptic facilitation through an increase in neurotrans-
mitter release at PF-PuC synapses [80].
2.1.2  Action mechanism for KARs-mediated depression of glutamate release at 
cerebellar PF-PuC synapses
Recently, in the same study discussed in the previous section [80], a transient 
synaptic depression of glutamate release with high concentrations of KA (3 μM) 
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was observed as reported for other different brain areas including thalamus, cortex, 
hippocampus, and amygdala [89–92]. This depression of glutamate release was pre-
vented in the presence of cAMP-RP (which inhibits the activation of PKA), but was 
not affected by any other experimental modification discussed above with respect 
to the facilitation of glutamate release. This fact may indicate that the synaptic 
depression is probably related to an AC/cAMP/PKA signaling pathway (as for facili-
tation of glutamate release), but without the coupling of Ca2+ to the AC. Therefore, 
Figure 1. 
KAR-mediated facilitation of glutamate release involving activation of adenylyl cyclase (AC) and downstream 
protein kinase A (PKA) at PF-PuC synapses of the cerebellum. (A) Time course of KA (3 μM) effect on 
eEPSCs amplitude in the absence (circles) and presence of NBQX (squares). Insets show traces before and after 
4 min of KA perfusion in the absence (1, 2) and in the presence of 10 μM NBQX (1′, 2′). (B) Quantification of 
modulation observed in (A) and dose-response curve. (C) Time course of the effect of KA on eEPSC amplitude 
in cAMP-Rp-treated slices. (D) Inhibition of PKA by cAMP-Rp (100 μM) or H-89 (2 μM), and activation of 
AC by forskolin (30 μM) prevented the facilitatory action of KA. Inhibition of PKC with calphostin C (1 μM) 
has no effect on the KA enhancement of the eEPSC amplitude. The facilitatory effect of KA is not affected in 
slices treated with pertussis toxin. Modified from [64].
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KA receptors have alternative mechanisms for facilitating and depressing glutamate 
release at PF-Pu synapses (Figures 1–3). In previous studies, investigating mossy 
fiber-CA3 hippocampal synapses [88, 89, 93, 94], as well as the amygdala [37] and 
cortex [36], a similar mechanism has been observed additionally involving the 
activation of a G-protein for the depressive effect that may well be also the case for 
these cerebellar synapses.
Although the presynaptic function of KARs facilitating glutamate release 
implies an increase in AC/cAMP/PKA signaling induced by the calcium calmodulin 
complex, KARs appear to be negatively associated with this pathway to carry out 
synaptic transmission of depression. Previous studies at hippocampal MF-CA3 
Figure 2. 
Facilitation of glutamate release mediated by KAR activation requires an increase of Ca2+ in the cytosol and 
Ca2+ calmodulin at cerebellar PF-PuC synapses. (A) Time course of KA (3 μM) effect on eEPSCs amplitude 
in control condition (circles) and in slices treated with philanthotoxin (squares). (B) Quantification of 
modulation observed in (A). (C) Time course of KA (3 μM) effect on eEPSCs amplitude in control condition 
(circles) and in the slices treated with 25 μM W-7 (squares). (D) Quantification of modulation observed in 
(A) and in the presence of 1 μM CMZ. Modified from [64].
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synapses and thalamocortical synapses, as well as at PF-PuC synapses, have 
reported that the depression of glutamate release mediated by presynaptic KARs 
occurs through a negative coupling to the AC/cAMP/PKA pathway, being actually 
evoked by the action of a PTx-sensitive protein G [80, 88, 92]. Despite the hypoth-
eses discussed above, it is also possible that these observed mechanisms reflect 
the presence of two different types of KARs, a clear objective being to clarify this 
hypothesis in future studies.
3. Conclusions
Regarding the role and mechanisms of KARs in the modulation of glutamate 
release in the cerebellum, new and recent data indicate that the KARs effecting 
facilitation of glutamate release and synaptic transmission show a mandatory 
dependence on adenylyl cyclase (AC) and cAMP-mediated protein kinase A (PKA) 
activity. Furthermore, the KAR-mediated facilitation of transmission is contingent 
on both external Ca2+ permeation into the cytosol through KAR and repletion of 
Figure 3. 
KAR-mediated modulation of glutamate release in the cerebellum. Actions of KARs depressing or facilitating 
glutamate release at the PF-PuC synapse. KAR activation by high concentrations of KA (>3 μM) depresses 
glutamate release at PF-PuC synapses, an effect that involves Gi/o protein and the adenylate cyclase/cAMP/
protein kinase A (AC/cAMP/PKA) pathway. KAR activation by low concentrations of kainate (<0.3 μM) only 
facilitates glutamate release following activation of a Ca2+-calmodulin/AC/cAMP/PKA pathway.
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intracellular Ca2+ stores. Finally, a major sensitivity of facilitation to calmodulin 
inhibition suggests that KARs are coupled through a Ca2+-calmodulin/AC/cAMP/
PKA pathway at PF-PuC synapses in the cerebellum. KARs seem to use the inhibi-
tion of the AC/cAMP/PKA pathway to mediate a depression of glutamate release at 
the same synapses, but the activation of the AC does not involve calcium calmodu-
lin and seems to be directly activated by a PTX-sensitive G protein.
Acknowledgements
Work related to kainate receptors in the corresponding author AR-M’s laboratory 
has been supported by Spanish Ministry of Education and Fundación Rodríguez-
Pascual grants.
Conflict of interest
The authors declare that the research was conducted in the absence of any com-
mercial or financial relationships that could be construed as a potential conflict of 
interest.
Author details
Pilar Losada-Ruiz, Rafael Falcón-Moya and Antonio Rodríguez-Moreno*
Department of Physiology, Anatomy and Cell Biology, Pablo de Olavide University, 
Seville, Spain
*Address all correspondence to: arodmor@upo.es
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
11
Kainate Receptors Modulating Glutamate Release in the Cerebellum
DOI: http://dx.doi.org/10.5772/intechopen.87984
[1] Lerma J, Paternain A, Rodríguez-
Moreno A, López-García JC. Molecular 
physiology of kainate receptors. 
Physiological Reviews. 2001;81:971-998. 
DOI: 10.1152/physrev.2001.81.3.971
[2] Traynelis SF, Wollmuth LP, McBain 
CJ, Menniti FS, Vance KM, Ogden KK, 
et al. Glutamate receptor ion channels: 
Structure, regulation, and function. 
Pharmacological Reviews. 2010;62: 
405-496. DOI: 10.1124/pr.109.002451
[3] Flores G, Negrete-Díaz JV, Carrión 
M, Andrade-Talavera Y, Bello SA, Sihra 
TS, et al. Excitatory amino acids in 
neurological and neurodegenerative 
disorders. In: Amino Acids in Human 
Nutrition and Health. Wallingford: CAB 
International; 2011. pp. 427-453
[4] Niswender CM, Conn PJ. Metabotropic 
glutamate receptors: Physiology, 
pharmacology, and disease. Annual 
Review of Pharmacology and Toxicology. 
2010;50:295-322. DOI: 10.1146/annurev.
pharmtox.011008.145533
[5] Nadler JV, Perry BW, Cotman 
CW. Intraventricular kainic acid 
preferentially destroys hippocampal 
pyramidal cells. Nature. 1978;271:676-
677. DOI: 10.1038/271676a0
[6] Falcón-Moya R, Sihra TS, Rodríguez-
Moreno A. Kainate receptors: Role 
in epilepsy. Frontiers in Molecular 
Neuroscience. 2018;11:217. DOI: 
10.3389/fnmol.2018.00217
[7] Lerma J, Marques JM. Kainate 
receptors in health and disease. Neuron. 
2013;80(2):292-311. DOI: 10.1016/j.
neuron.2013.09.045
[8] Paternain AV, Rodríguez-Moreno 
A, Villarroel A, Lerma J. Activation 
and desensitization properties of 
native and recombinant kainate 
receptors. Neuropharmacology. 
1998;37(10-11):1249-1259
[9] Lee DL, editor. The Biology of the 
Nematodes. Boca Raton: CRC Press. 
Taylor and Francis Group; 2010
[10] Li Y, Dharkar P, Han TH, Serpe 
M, Lee CH, Mayer ML. Novel 
functional properties of Drosophila 
CNS glutamate receptors. Neuron. 
2016;92(5):1036-1048
[11] Somogyi P, Eshhar N, Teichberg VI, 
Roberts JDB. Subcellular localization of 
a putative kainate receptor in Bergmann 
glial cells using a monoclonal antibody 
in the chick and fish cerebellar cortex. 
Neuroscience. 1990;35(1):9-30
[12] Atoji Y, Sarkar S. Localization of 
AMPA, kainate, and NMDA receptor 
mRNAs in the pigeon cerebellum. 
Journal of Chemical Neuroanatomy. 
2019;98:71-79
[13] Estabel J, König N, Exbrayat 
JM. AMPA/kainate receptors permeable 
to divalent cations in amphibian 
central nervous system. Life Sciences. 
1999;64(8):607-616
[14] Huettner JE. Kainate receptors 
and synaptic transmission. Progress in 
Neurobiology. 2003;70(5):387-407. DOI: 
10.1016/S0301-0082(03)00122-9
[15] Jane DE, Lodge D, Collingridge 
GL. Kainate receptors: Pharmacology, 
function and therapeutic potential. 
Neuropharmacology. 2009;56(1):90-113. 
DOI: 10.1016/j.neuropharm.2008.08.023
[16] Paternain AV, Herrera MT, Nieto 
MA, Lerma J. GluR5 and GluR6 
kainate receptor subunits coexist in 
hippocampal neurons and coassemble 
to form functional receptors. Journal of 
Neuroscience. 2000;20(1):196-205. DOI: 
10.1523/JNEUROSCI.20-01-00196.2000
[17] Rodríguez-Moreno A, Sihra TS. 
Metabotropic actions of kainate 
receptors in the CNS. Journal of 
References




[18] Rodríguez-Moreno A, Sihra TS. 
Kainate receptors with a metabotropic 
modus operandi. Trends in 
Neurosciences. 2007;30(12):630-637. 
DOI: 10.1016/j.tins.2007.10.001
[19] Sihra TS, Rodríguez-Moreno 
A. Metabotropic actions of kainate 
receptors in the control of GABA 
release. In: Kainate Receptors. Boston, 
MA: Springer; 2011. pp. 1-10
[20] Rodríguez-Moreno A, Sihra 
TS. Metabotropic actions of kainate 
receptors in the control of glutamate 
release in the hippocampus. In: Kainate 
Receptors. Boston, MA: Springer; 2011. 
pp. 39-48
[21] Sihra TS, Rodríguez-Moreno 
A. Presynaptic kainate receptor-
mediated bidirectional modulatory 
actions: Mechanisms. Neurochemistry 
International. 2013;62(7):982-987. DOI: 
10.1016/j.neuint.2013.03.012
[22] Negrete-Díaz JV, Sihra TS, Flores G, 
Rodríguez-Moreno A. Non-canonical 
mechanisms of presynaptic kainate 
receptors controlling glutamate release. 
Frontiers in Molecular Neuroscience. 
2018;11:128. DOI: 10.3389/
fnmol.2018.00128
[23] Sihra TS, Flores G, Rodríguez-
Moreno A. Kainate receptors: Multiple 
roles in neuronal plasticity. The 
Neuroscientist. 2014;20(1):29-43. DOI: 
10.1177/1073858413478196
[24] Rodríguez-Moreno A, Herreras 
O, Lerma J. Kainate receptors 
presynaptically downregulate GABAergic 
inhibition in the rat hippocampus. 
Neuron. 1997;19(4):893-901. DOI: 
10.1016/S0896-6273(00)80970-8
[25] Mulle C, Sailer A, Pérez-Otaño I, 
Dickinson-Anson H, Castillo PE, Bureau 
I, et al. Altered synaptic physiology 
and reduced susceptibility to kainite-
induced seizures in GluR6-deficient 
mice. Nature. 1998;392:601-605
[26] Smolders I, Bortolotto ZA, 
Clarke VR, Warre R, Khan GM, 
O’Neill MJ, et al. Antagonists of 
GLU(K5)-containing kainate receptors 
prevent pilocarpine-induced limbic 
seizures. Nature Neuroscience. 
2002;5(8):796-804
[27] Fritsch B, Reis J, Gasior M, 
Kaminski RM, Rogawski MA. Role 
of GluK1 kainate receptors in 
seizures, epileptic discharges, and 
epileptogenesis. The Journal of 
Neuroscience. 2014;34(17):5765-5775. 
DOI: 10.1523/JNEUROSCI.5307-13.2014
[28] Rodríguez-Moreno A, Lerma 
J. Kainate receptor modulation 
of GABA release involves a 
metabotropic function. Neuron. 
1998;20(6):1211-1218. DOI: 10.1016/
S0896-6273(00)80501-2
[29] Rodríguez-Moreno A, López-
García JC, Lerma J. Two populations 
of kainate receptors with separate 
signaling mechanisms in hippocampal 
interneurons. Proceedings of the 
National Academy of Sciences. 
2000;97(3):1293-1298. DOI: 10.1073/
pnas.97.3.1293
[30] Artinian J, Peret A, Marti G, 
Epsztein J, Crépel V. Synaptic kainate 
receptors in interplay with INaP shift 
the sparse firing of dentate granule 
cells to a sustained rhythmic mode in 
temporal lobe epilepsy. The Journal of 
Neuroscience. 2011;31(30):10811-10818. 
DOI: 10.1523/JNEUROSCI.0388-11.2011
[31] Artinian J, Peret A, Mircheva Y, 
Marti G, Crépel V. Impaired neuronal 
operation through aberrant intrinsic 
plasticity in epilepsy. Annals of 
Neurology. 2015;77(4):592-606. DOI: 
10.1002/ana.24348
13
Kainate Receptors Modulating Glutamate Release in the Cerebellum
DOI: http://dx.doi.org/10.5772/intechopen.87984
[32] Peret A, Christie LA, Ouedraogo 
DW, Gorlewicz A, Epsztein J, Mulle C, 
et al. Contribution of aberrant GluK2-
containing kainate receptors to chronic 
seizures in temporal lobe epilepsy. 
Cell Reports. 2014;8(2):347-354. DOI: 
10.1016/j.celrep.2014.06.032
[33] Crépel V, Mulle C. Physiopathology 
of kainate receptors in epilepsy. Current 
Opinion in Pharmacology. 2015;20:83-
88. DOI: 10.1016/j.coph.2014.11.012
[34] Sander T, Hildmann T, Kretz 
R, Fürst R, Sailer U, Bauer G, et al. 
Allelic association of juvenile absence 
epilepsy with a GluR5 kainate receptor 
gene (GRIK1) polymorphism. 
American Journal of Medical Genetics. 
1997;74:416-421
[35] Li JM, Zeng YJ, Peng F, Li L, Yang 
TH, Hong Z, et al. Aberrant glutamate 
receptor 5 expression in temporal 
lobe epilepsy lesions. Brain Research. 
2010;1311:166-174
[36] Swanson GT. Targeting AMPA 
and kainate receptors in neurological 
disease: Therapies on the horizon? 
Neuropsychopharmacology. 
2009;34:249-250
[37] Sanchez-Gomez MV, Matute 
C. AMPA and kainate receptors 
each mediate excitotoxicity in 
oligodendroglial cultures. Neurobiology 
of Disease. 1999;6:475-485. DOI: 
10.1006/nbdi.1999.0264
[38] Matute C. Characteristics of acute 
and chronic kainate excitotoxic damage 
to the optic nerve. Proceedings of the 
National Academy of Sciences of the 
United States of America. 1998;95:10229-
10234. DOI: 10.1073/pnas.95.17.10229
[39] Tekkok SB, Goldberg MP. AMPA/
kainate receptor activation mediates 
hypoxic oligodendrocyte death 
and axonal injury in cerebral white 
matter. The Journal of Neuroscience. 
2001;21:4237-4248. DOI: 10.1523/
JNEUROSCI.21-12-04237.2001
[40] Xu J, Liu Y, Zhang 
GY. Neuroprotection of GluR5-
containing kainate receptor activation 
again ischemic brain injury through 
decreasing tyrosine phosphorylation of 
N-methyl-D-aspartate reeptors mediated 
by SRC kinase. The Journal of Biological 
Chemistry. 2008;283:29355-29366
[41] O’Neill MJ, Bogaert L, Hicks CA, 
Bond A, Ward MA, Ebinger G, et al. 
LY377770, a novel iGlu5 kainate receptor 
antagonist with neuroprotective effects 
in global and focal cerebral ischaemia. 
Neuropharmacology. 2000;39:1575-1588. 
DOI: 10.1016/S0028-3908(99)00250-6
[42] Aronica E, Dickson DW, Kress Y, 
Morrison JH, Zukin RS. Non-plaque 
dystrophic dendrites in Alzheimer 
hippocampus: A new pathological 




[43] Luquim MR, Saldise L, Guillén J, 
et al. Does increased excitatory drive 
from the subthalamic nucleus contribute 
to dopaminergic neuronal death in 
Parkinson’s disease? Experimental 
Neurology. 2006;201:407-415
[44] Carson KM, Andresen JM, Orr 
HT. Emerging pathogenic pathways in 
the spinocerebellar ataxias. Current 
Opinion in Genetics and Development. 
2009;19:247-253
[45] Wagster MV, Hedreen JC, Peyser 
CE, Folstein SE, Ross CA. Selective loss 
of [3H] kainic acid and [3H] AMPA 
binding in layer VI of frontal cortex 
in Huntington’s disease. Experimental 
Neurology. 1994;127:70-75. DOI: 
10.1006/exnr.1994.1081
[46] Rubinsztein DC, Leggo J, Chiano 
M, Dodge A, Norbury G, Rosser E, et al. 
Biogenic Amines in Neurotransmission and Human Disease
14
Genotypes at the GluR6 kainate receptor 
locus are associated with variation in 
the age of onset of Huntington disease. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 1997;94:3872-3876. DOI: 
10.1073/pnas.94.8.3872
[47] MacDonald ME, Vonsattel JP, 
Shrinidhi J, Couropmitree NN, Cupples 
LA, Bird ED, et al. Evidence for the 
GluR6 gene associated with younger 
onset age of Huntington’s disease. 
Neurology. 1999;53:1330-1332. DOI: 
10.1212/WNL.53.6.1330
[48] Garey LJ, Von Bussmann KA, 
Hirsch SR. Decreasednumerical density 
of kainate receptor-positive neurons 
in the orbitofrontal cortex of chronic 
schizophrenics. Experimental Brain 
Research. 2006;173:234-242. DOI: 
10.1007/s00221-006-0396-8
[49] Begni S, Popoli M, Moraschi 
S, Bignotti S, Tura GB, Gennarelli 
M. Association between the ionotropic 
glutamate receptor kainate 3 (GRIK3) 
ser310ala polymorphism and 
schizophrenia. Molecular Psychiatry. 
2002;7:416-418. DOI: 10.1038/
sj.mp.4000987
[50] Schiffer HH, Heinemann 
SF. Association of the human kainate 
receptor GluR7 gene (GRIK3) with 
recurrent major depressive disorder. 
American Journal of Medical Genetics. 
Part B, Neuropsychiatric Genetics. 
2007;144:20-26. DOI: 10.1002/
ajmg.b.30374
[51] Pickard BS, Malloy MP, Christoforou 
A, et al. Cytogenetic and genetic 
evidence supports a role for the kainate-
type glutamate receptor gene, GRIK4, 
in schizophrenia and bipolar disorder. 
Molecular Psychiatry. 2006;11:847-857. 
DOI: 10.1038/sj.mp.4001867
[52] Wilson GM, Flibotte S, Chopra 
V, Melnyk BL, Honer WG, Holt 
RA. DNA copy number analysis in 
bipolar disorder and schizophrenia 
reveals aberrations in genes involved in 
glutamate signaling. Human Molecular 
Genetics. 2006;15:743-749. DOI: 
10.1093/hmg/ddi489
[53] Motazacker MM, Rost BR, Hucho 
T, Garshasbi M, Kahrizi K, Ullmann 
R, et al. A defect in the ionotropic 
glutamate receptor 6 gene (GRIK2) is 
associated with autosomal recessive 
mental retardation. American Journal of 
Human Genetics. 2007;81:792-798. DOI: 
10.1086/521275
[54] Jamain S, Betancur C, Mol Quach 
H, Philippe A, Fellous M, Giros B, 
et al. Linkage and association of the 
glutamate receptor 6 gene with autism. 
Molecular Psychiatry. 2002;7:302-310. 
DOI: 10.1038/sj.mp.4000979
[55] Bowie D. Ionotropic glutamate 
receptors & CNS disorders. CNS & 
Neurological Disorders Drug Targets. 
2008;7:129-143
[56] Matute C. Therapeutic potential of 
kainate receptors. CNS Neuroscience 
and Therapeutics. 2011;17(6):661-669. 
DOI: 10.1111/j.1755-5949.2010.00204.x
[57] Pemberton KE, Belcher SM, 
Ripellino JA, Howe JR. High-affinity 
kainate-type ion channels in rat 
cerebellar granule cells. The Journal of 
Physiology. 1998;510(2):401-420. DOI: 
10.1111/j.1469-7793.1998.401bk.x
[58] Smith TC, Wang LY, Howe 
JR. Distinct kainate receptor phenotypes 
in immature and mature mouse 
cerebellar granule cells. The Journal of 
Physiology. 1999;517(1):51-58. DOI: 
10.1111/j.1469-7793.1999.0051z.x
[59] Spiliopoulos K, Fragioudaki K, 
Giompres P, Kouvelas E, Mitsacos 
A. Expression of GluR6 kainate receptor 
subunit in granular layer of weaver 




Kainate Receptors Modulating Glutamate Release in the Cerebellum
DOI: http://dx.doi.org/10.5772/intechopen.87984
[60] Tyrrell T, Willshaw D. Cerebellar 
cortex: Its simulation and the relevance of 
Marr’s theory. Philosophical Transactions 
of the Royal Society of London. Series B: 
Biological Sciences. 1992;336(1277):239-
257. DOI: 10.1098/rstb.1992.0059
[61] Wadiche JI, Jahr CE. Multivesicular 
release at climbing fiber-Purkinje cell 
synapses. Neuron. 2001;32(2):301-313. 
DOI: 10.1016/S0896-6273(01)00488-3
[62] Crépel F. Role of presynaptic 
kainate receptors at parallel-fiber-
purkinje cell synapses in induction of 
cerebellar LTD: Interplay with climbing 
fiber input. Journal of Neurophysiology. 
2009;102:965-973
[63] Rodríguez-Moreno A, Paulsen 
O. Spike timing-dependent long-term 
depression requires presynaptic NMDA 
receptors. Nature Neuroscience. 
2008;11:744-745
[64] Banerjee A, Meredith RM, 
Rodríguez-Moreno A, Mierau SB, 
Auberson YP, Paulsen O. Double 
dissociation of spike timing-dependent 
potentiation and depression by subunit-
preferring NMDA receptors antagonists 
in mouse barrel cortex. Cerebral Cortex. 
2009;19:2959-2969
[65] Rodríguez-Moreno A, Banerjee A, 
Paulsen O. Presynaptic NMDA receptors 
and spike timing-dependent depression 
at cortical synapses. Frontiers in 
Synaptic Neuroscience. 2010;2:18. DOI: 
10.3389/fnsyn.2010.00018
[66] Rodríguez-Moreno A, Kohl 
MM, Reeve J, Eaton TR, Collins HA, 
Anderson HL, et al. Presynaptic 
induction and expression of timing-
dependent long-term depression 
demonstrated by compartment specific 
photorelease of a use-dependent 
NMDA antagonist. The Journal of 
Neuroscience. 2011;31:8564-8569
[67] Buchanan KA, Blackman AV, 
Moreau AW, Elgar D, Costa RP, Lalanne 
T, et al. Target-specific expression 
of presynaptic NMDA receptors in 
neocortical microcircuits. Neuron. 
2012;75:451-466
[68] Rodríguez-Moreno A, González-
Rueda A, Banerjee A, Upton ML, 
Craig M, Paulsen O. Presynaptic self-
depression at developing neocortical 
synapses. Neuron. 2013;77:35-42
[69] Banerjee A, González-Rueda 
A, Sampaio-Baptista C, Paulse O, 
Rodríguez-Moreno A. Distinct 
mechanisms of spike timing-dependent 
LTD at vertical and horizontal inputs 
onto L2/3 pyramidal neurons in mouse 
barrel cortex. Physiological Reports. 
2014;2(3):1-11. DOI: 10.1002/phy2.271
[70] Komuro H, Rakic P. Modulation 
of neuronal migration by NMDA 
receptors. Science. 1993;260(5104):95-
97. DOI: 10.1126/science.8096653
[71] Rabacchi S, Bailly Y, Delhaye-
Bouchaud N, Mariani J. Involvement 
of the N-methyl d-aspartate (NMDA) 
receptor in synapse elimination during 
cerebellar development. Science. 
1992;256(5065):1823-1825. DOI: 
10.1126/science.1352066
[72] Maiti A, Salles KS, Grassi S, Abood 
LG. Behavior and receptor changes after 
kainate lesioning of nodular cerebellum. 
Pharmacology Biochemistry and 
Behavior. 1986;25(3):589-594. DOI: 
10.1016/0091-3057(86)90146-2
[73] de Vera N, Camón L, Martínez 
E. Cerebral distribution of polyamines 
in kainic acid-induced models of 
status epilepticus and ataxia in 
rats. Overproduction of putrescine 




[74] Yamaguchi T, Hayashi K, 
Murakami H, Maruyama S, Yamaguchi 
M. Distribution and characterization of 
Biogenic Amines in Neurotransmission and Human Disease
16
the glutamate receptors in the CNS of 
ataxic mutant mouse. Neurochemical 
Research. 1984;9(4):497-505. DOI: 
10.1007/BF00964376
[75] Andoh T, Kishi H, Motoki K, 
Nakanishi K, Kuraishi Y, Muraguchi A. 
Protective effect of IL-18 on kainate-
and IL-1 β-induced cerebellar ataxia 
in mice. Journal of Immunology. 
2008;180:2322-2328. DOI: 10.4049/
jimmunol.180.4.2322
[76] Harrison PJ, Barton AJ, Najlerahim 
A, Pearson RC. Distribution of a 
kainate/AMPA receptor mRNA 
in normal and Alzheimer brain. 
Neuroreport. 1990;1(2):149-152
[77] Bullock WM, Cardon K, Bustillo 
J, Roberts RC, Perrone-Bizzozero NI. 
Altered expression of genes involved 
in GABAergic transmission and 
neuromodulation of granule cell activity 
in the cerebellum of schizophrenia 
patients. American Journal of 
Psychiatry. 2008;165(12):1594-1603. 
DOI: 10.1176/appi.ajp.2008.07121845
[78] Korf J, Postema F. Regional 
calcium accumulation and cation 
shifts in rat brain by kainate. Journal of 
Neurochemistry. 1984;43(4):1052-1060. 
DOI: 10.1111/j.1471-4159.1984.tb12843.x
[79] Savidge JR, Bleakman D, Bristow 
DR. Identification of kainate receptor-
mediated intracellular calcium increases 
in cultured rat cerebellar granule 
cells. Journal of Neurochemistry. 
1997;69(4):1763-1766. DOI: 
10.1046/j.1471-4159.1997.69041763.x
[80] Falcón-Moya R, Losada-Ruiz 
P, Sihra TS, Rodríguez-Moreno 
A. Cerebellar Kainate receptor-mediated 
facilitation of glutamate release requires 
Ca2+−calmodulin and PKA. Frontiers in 
Molecular Neuroscience. 2018;11:1-10. 
DOI: 10.3389/fnmol.2018.00195
[81] Bahn S, Volk B, Wisden W.  
Kainate receptor gene expression 
in the developing rat brain. 
Journal of Neuroscience. 
1994;14(9):5525-5547. DOI: 10.1523/
JNEUROSCI.14-09-05525.1994
[82] Bettler B, Boulter J, Hermans-
Borgmeyer I, O’Shea-Greenfield A, 
Deneris ES, Moll C, et al. Cloning 
of a novel glutamate receptor 
subunit, GluR5: Expression in the 
nervous system during development. 
Neuron. 1990;5(5):583-595. DOI: 
10.1016/0896-6273(90)90213-y
[83] Herb A, Burnashev N, Werner 
P, Sakmann B, Wisden W, Seeburg 
PH. The KA-2 subunit of excitatory 
amino acid receptors shows widespread 
expression in brain and forms ion 
channels with distantly related subunits. 
Neuron. 1992;8(4):775-785. DOI: 
10.1016/0896-6273(92)90098-x
[84] Petralia RS, Wang YX, Wenthold 
RJ. Histological and ultrastructural 
localization of the kainate receptor 
subunits, KA2 and GluR6/7, in 
the rat nervous system using 
selective antipeptide antibodies. 
Journal of Comparative Neurology. 
1994;349(1):85-110. DOI: 10.1002/
cne.903490107
[85] Swanson GT, Feldmeyer D, Kaneda 
M, Cull-Candy SG. Effect of RNA 
editing and subunit co-assembly single-
channel properties of recombinant 
kainate receptors. Journal of Physiology. 
1996;492:129-142
[86] Delaney AJ, Jahr CE. Kainate 
receptors differentially regulate release 
at two parallel fiber synapses. Neuron. 
2002;36(3):475-482. DOI: 10.1016/
s08966273(02)01008-5
[87] Rodríguez-Moreno A, Sihra 
TS. Presynaptic kainate receptor 
facilitation of glutamate release 
involves protein kinase A in the rat 




Kainate Receptors Modulating Glutamate Release in the Cerebellum
DOI: http://dx.doi.org/10.5772/intechopen.87984
[88] Negrete-Díaz JV, Sihra TS, 
Delgado-García JM, Rodríguez-Moreno 
A. Kainate receptor–mediated inhibition 
of glutamate release involves protein 
kinase A in the mouse hippocampus. 
Journal of Neurophysiology. 
2006;96(4):1829-1837. DOI: 10.1152/
jn.00280.2006
[89] Andrade-Talavera Y, Duque-Feria 
P, Negrete-Díaz JV, Sihra TS, Flores 
G, Rodríguez-Moreno A. Presynaptic 
kainate receptor-mediated facilitation 
of glutamate release involves Ca2+-
calmodulin at mossy fiber-CA3 
synapses. Journal of Neurochemistry. 
2012;122(5):891-899. DOI: 
10.1111/j.1471-4159.2012.07844.x
[90] Rodríguez-Moreno A, Sihra 
TS. Presynaptic kainate receptor-
mediated facilitation of glutamate 
release involves Ca2+–calmodulin and 
PKA in cerebrocortical synaptosomes. 
FEBS Letters. 2013;587(6):788-792. 
DOI: 10.1016/j.febslet.2013.01.071
[91] Negrete-Díaz JV, Duque-Feria 
P, Andrade-Talavera Y, Carrión 
M, Flores G, Rodríguez-Moreno 
A. Kainate receptor-mediated 
depression of glutamatergic 
transmission involving protein kinase 
A in the lateral amygdala. Journal of 
Neurochemistry. 2012;121(1):36-43. 
DOI: 10.1111/j.1471-4159.2012.07665.x
[92] Andrade-Talavera Y, Duque-Feria 
P, Sihra TS, Rodríguez-Moreno A. Pre-
synaptic kainate receptor-mediated 
facilitation of glutamate release 
involves PKA and Ca2+-calmodulin at 
thalamocortical synapses. Journal of 
Neurochemistry. 2013;126(5):565-578. 
DOI: 10.1016/j.febslet.2013.01.071
[93] Negrete-Díaz JV, Sihra TS, 
Delgado-García JM, Rodríguez-
Moreno A. Kainate receptor-mediated 
presynaptic inhibition converges 
with presynaptic inhibition mediated 
by Group II mGluRs and long-term 
depression at the hippocampal mossy 
fiber-CA3 synapse. Journal of Neural 
Transmission. 2007;114(11):1425-1431. 
DOI: 10.1007/s00702-007-0750-4
[94] Lyon L, Borel M, Carrión M, 
Kew JN, Corti C, Harrison PJ, et al. 
Hippocampal mossy fiber long-term 
depression in Grm2/3 double knockout 
mice. Synapse. 2011;65(9):945-954. 
DOI: 10.1002/syn.20923
